58 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
32
Sulfonamides as Selective Na

Amgen
27
Sulfonamides as Selective Na

Amgen
19
Sulfonamides as Selective Na

Amgen
17
Discovery of Aryl Sulfonamides as Isoform-Selective Inhibitors of NaV1.7 with Efficacy in Rodent Pain Models.

Xenon Pharmaceuticals
18
Voltage-Gated Sodium Channels: Structure, Function, Pharmacology, and Clinical Indications.

Merck Research Laboratories
39
Ion channels as therapeutic targets: a drug discovery perspective.

Pfizer
7
Inhibition of NaV1.6 sodium channel currents by a novel series of 1,4-disubstituted-triazole derivatives obtained via copper-catalyzed click chemistry.

University of Parma
2
Lactam-stabilized helical analogues of the analgesicµ-conotoxin KIIIA.

Monash University
18
Oxadiazolylindazole sodium channel modulators are neuroprotective toward hippocampal neurones.

University College London
27
Discovery of novel cyclopentane carboxylic acids as potent and selective inhibitors of NaV1.7.

Xenon Pharmaceuticals Inc.
21
2-Aminopyridines as Potent and Selective Nav1.8 Inhibitors Exhibiting Efficacy in a Nonhuman Primate Pain Model.

Merck & Co.
14
Advances in Epilepsy: Mechanisms, Clinical Trials, and Drug Therapies.

Sichuan University
27
Identification of Selective Acyl Sulfonamide-Cycloalkylether Inhibitors of the Voltage-Gated Sodium Channel (Na

Xenon Pharmaceuticals
17
Inhibition of Na

Daiichi Sankyo Co.
49
Discovery of (R)-(3-fluoropyrrolidin-1-yl)(6-((5-(trifluoromethyl)pyridin-2-yl)oxy)quinolin-2-yl)methanone (ABBV-318) and analogs as small molecule Na

Abbvie
6
5-Oxopyrrolidine-3-carboxamides as Na

Smith, Gambrell & Russell
23
Discovery of Selective Inhibitors of Na

Siteone Therapeutics
6
Discovery and Characterization of Potent, Efficacious, Orally Available Antimalarial Plasmepsin X Inhibitors and Preclinical Safety Assessment of

Ucb
17
Discovery of Acyl-sulfonamide Na

Genentech
24
Development of ProTx-II Analogues as Highly Selective Peptide Blockers of Na

Merck
7
Functional Characterization of the Nemertide α Family of Peptide Toxins.

Uppsala University
28
Identification of aryl sulfonamides as novel and potent inhibitors of Na

Xenon Pharmaceuticals
2
Discovery of Dihydrobenzoxazepinone (GS-6615) Late Sodium Current Inhibitor (Late I

Gilead Sciences
1
The E15R Point Mutation in Scorpion Toxin Cn2 Uncouples Its Depressant and Excitatory Activities on Human Na

The University of Queensland
18
Discovery of Arylsulfonamide Na

Merck
9
Design, Synthesis, and Pharmacological Evaluation of Analogues Derived from the PLEV Tetrapeptide as Protein-Protein Interaction Modulators of Voltage-Gated Sodium Channel 1.6.

TBA
20
Discovery of DS-1971a, a Potent, Selective Na

Daiichi Sankyo
37
Application of a Parallel Synthetic Strategy in the Discovery of Biaryl Acyl Sulfonamides as Efficient and Selective NaV1.7 Inhibitors.

Amgen
21
Structure- and Ligand-Based Discovery of Chromane Arylsulfonamide Na

Genentech
29
The discovery and optimization of benzimidazoles as selective Na

Pfizer
17
Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform Na

Siteone Therapeutics
27
Substituted Indazoles as Nav1.7 Blockers for the Treatment of Pain.

Abbvie
23
Design of Conformationally Constrained Acyl Sulfonamide Isosteres: Identification of N-([1,2,4]Triazolo[4,3- a]pyridin-3-yl)methane-sulfonamides as Potent and Selective hNa

Xenon Pharmaceuticals
4
Peptide therapeutics from venom: Current status and potential.

Peptides International
30
Discovery of morpholine-based aryl sulfonamides as Na

Bristol Myers Squibb
14
Highly potent and selective Na

Pfizer
41
Discovery of Tarantula Venom-Derived Na

Amgen
27
Discovery of Clinical Candidate 4-[2-(5-Amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): Design and Optimization of Diaryl Ether Aryl Sulfonamides as Selective Inhibitors of Na

Icagen
57
QUINOLINES AS MODULATORS OF POLRMT

Pretzel Therapeutics
12
Fluoropyrrolopyridine compound and application thereof

Wuxi Life Fountain Biotech Co.
28
METHOD FOR PRODUCING ARYLAMIDE DERIVATIVE

Chugai Seiyaku Kabushiki Kaisha
8
HETEROCYCLIC COMPOUND, AND INTERMEDIATE THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOF

Wuhan LL Science and Technology Development Co.
122
Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors

Valo Health
9
BENZYLAMINE OR BENZYL ALCOHOL DERIVATIVE AND USES THEREOF

Chengdu Hyperway Pharmaceuticals
86
Heterocyclic compounds as RET kinase inhibitors

Cancer Research Technology
14
7-phenylethylamino-4H-pyrimido[4,5-d][1,3]oxazin-2-one compounds as mutant IDH1 and IDH2 inhibitors

Eli Lilly
37
Thienodiazepine derivatives and application thereof

Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang)
256
Substituted piperidine compound and use thereof

Takeda Pharmaceutical
173
ASK1 inhibiting agents

Biogen Ma
440
6-aminopyridin-3-yl thiazoles as modulators of RORγT

Janssen Pharmaceutica
16
Heterocyclic compounds as kinase inhibitors

Translational Drug Development
38
Morphan and morphinan analogues, and methods of use

Alkermes Pharma Ireland
37
Bicyclic heterocycles as FGFR4 inhibitors

Incyte
12
Anticoronaviral compounds and compositions, their pharmaceutical uses and materials for their synthesis

Pfizer
37
Piperazinyl methanone NAAA inhibitors

University of California
29
Hexahydrodibenzo[a,g]quinolizine compound, preparation method thereof, pharmaceutical composition and use thereof

Shanghai Institute of Material Medica, Chinese Academy of Sciences
87
Bicyclic heterocycle compounds methods of use thereof for the treatment of herpes viruses

Merck Sharp & Dohme
2
Development of a technique to determine bicyclomycin-rho binding and stoichiometry by isothermal titration calorimetry and mass spectrometry.

University of North Carolina